These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 16782033)
1. A role for activation-induced cytidine deaminase in the host response against a transforming retrovirus. Gourzi P; Leonova T; Papavasiliou FN Immunity; 2006 Jun; 24(6):779-786. PubMed ID: 16782033 [TBL] [Abstract][Full Text] [Related]
2. AID for innate immunity to retroviral transformation. Schlissel MS; Kuo TC Immunity; 2006 Jun; 24(6):671-672. PubMed ID: 16782023 [TBL] [Abstract][Full Text] [Related]
3. Class switch recombination and somatic hypermutation of virus-neutralizing antibodies are not essential for control of friend retrovirus infection. Kato M; Tsuji-Kawahara S; Kawasaki Y; Kinoshita S; Chikaishi T; Takamura S; Fujisawa M; Kawada A; Miyazawa M J Virol; 2015 Jan; 89(2):1468-73. PubMed ID: 25378499 [TBL] [Abstract][Full Text] [Related]
4. A role for host activation-induced cytidine deaminase in innate immune defense against KSHV. Bekerman E; Jeon D; Ardolino M; Coscoy L PLoS Pathog; 2013; 9(11):e1003748. PubMed ID: 24244169 [TBL] [Abstract][Full Text] [Related]
5. Viral induction of AID is independent of the interferon and the Toll-like receptor signaling pathways but requires NF-kappaB. Gourzi P; Leonova T; Papavasiliou FN J Exp Med; 2007 Feb; 204(2):259-65. PubMed ID: 17242162 [TBL] [Abstract][Full Text] [Related]
6. Mutation of the Lyn tyrosine kinase delays the progression of Friend virus induced erythroleukemia without affecting susceptibility. Subramanian A; Hegde S; Correll PH; Paulson RF Leuk Res; 2006 Sep; 30(9):1141-9. PubMed ID: 16527351 [TBL] [Abstract][Full Text] [Related]
7. Reassessment of murine APOBEC1 as a retrovirus restriction factor in vivo. Barrett BS; Guo K; Harper MS; Li SX; Heilman KJ; Davidson NO; Santiago ML Virology; 2014 Nov; 468-470():601-608. PubMed ID: 25303118 [TBL] [Abstract][Full Text] [Related]
8. Incorporation of mouse APOBEC3 into murine leukemia virus virions decreases the activity and fidelity of reverse transcriptase. Boi S; Kolokithas A; Shepard J; Linwood R; Rosenke K; Van Dis E; Malik F; Evans LH J Virol; 2014 Jul; 88(13):7659-62. PubMed ID: 24719421 [TBL] [Abstract][Full Text] [Related]
9. Cell-free transmission of Fv-4 resistance gene product controlling Friend leukemia virus-induced leukemogenesis: a unique mechanism for interference with viral infection. Kitagawa M; Aizawa S; Kamisaku H; Ikeda H; Hirokawa K; Sado T Blood; 1995 Aug; 86(4):1557-63. PubMed ID: 7632964 [TBL] [Abstract][Full Text] [Related]
10. Murine Leukemia Virus P50 Protein Counteracts APOBEC3 by Blocking Its Packaging. Zhao W; Akkawi C; Mougel M; Ross SR J Virol; 2020 Aug; 94(18):. PubMed ID: 32641479 [TBL] [Abstract][Full Text] [Related]
11. AID-expressing epithelium is protected from oncogenic transformation by an NKG2D surveillance pathway. Pérez-García A; Pérez-Durán P; Wossning T; Sernandez IV; Mur SM; Cañamero M; Real FX; Ramiro AR EMBO Mol Med; 2015 Oct; 7(10):1327-36. PubMed ID: 26282919 [TBL] [Abstract][Full Text] [Related]
12. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. Muramatsu M; Sankaranand VS; Anant S; Sugai M; Kinoshita K; Davidson NO; Honjo T J Biol Chem; 1999 Jun; 274(26):18470-6. PubMed ID: 10373455 [TBL] [Abstract][Full Text] [Related]
13. The AID antibody diversification enzyme is regulated by protein kinase A phosphorylation. Basu U; Chaudhuri J; Alpert C; Dutt S; Ranganath S; Li G; Schrum JP; Manis JP; Alt FW Nature; 2005 Nov; 438(7067):508-11. PubMed ID: 16251902 [TBL] [Abstract][Full Text] [Related]
14. Negative regulation of activation-induced cytidine deaminase in B cells. Muto T; Okazaki IM; Yamada S; Tanaka Y; Kinoshita K; Muramatsu M; Nagaoka H; Honjo T Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2752-7. PubMed ID: 16477013 [TBL] [Abstract][Full Text] [Related]
15. Cytogenetic studies on abelson-virus-induced mouse leukemias. Klein G; Ohno S; Rosenberg N; Wiener F; Spira J; Baltimore D Int J Cancer; 1980 Jun; 25(6):805-11. PubMed ID: 14768711 [TBL] [Abstract][Full Text] [Related]
16. A tumor-suppressor function for NFATc3 in T-cell lymphomagenesis by murine leukemia virus. Glud SZ; Sørensen AB; Andrulis M; Wang B; Kondo E; Jessen R; Krenacs L; Stelkovics E; Wabl M; Serfling E; Palmetshofer A; Pedersen FS Blood; 2005 Nov; 106(10):3546-52. PubMed ID: 16051745 [TBL] [Abstract][Full Text] [Related]
17. Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia. Nazarov V; Hilbert D; Wolff L Virology; 1994 Dec; 205(2):479-85. PubMed ID: 7975249 [TBL] [Abstract][Full Text] [Related]
18. Decreased virus population diversity in p53-null mice infected with weakly oncogenic Abelson virus. Marchlik E; Kalman R; Rosenberg N J Virol; 2005 Sep; 79(18):11618-26. PubMed ID: 16140739 [TBL] [Abstract][Full Text] [Related]
19. Novel role of CD8(+) T cells and major histocompatibility complex class I genes in the generation of protective CD4(+) Th1 responses during retrovirus infection in mice. Peterson KE; Stromnes I; Messer R; Hasenkrug K; Chesebro B J Virol; 2002 Aug; 76(16):7942-8. PubMed ID: 12133998 [TBL] [Abstract][Full Text] [Related]
20. Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease. Kawabata H; Niwa A; Tsuji-Kawahara S; Uenishi H; Iwanami N; Matsukuma H; Abe H; Tabata N; Matsumura H; Miyazawa M Int Immunol; 2006 Jan; 18(1):183-98. PubMed ID: 16352628 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]